Indication
Atopic dermatitis
Atopic dermatitis is a chronic, relapsing inflammatory disorder of the skin and the most common type of eczema. Read more about Atopic dermatitis
1,206 drugs 329 manufacturers
Drugs that treat it
Common Atopic dermatitis therapies.
BETAMETHASONE SOD PHOS-ACETATE (betamethasone acetate/betamethasone sodium phosphate)
BETAMETHASONE DIPROP AUGMENTED (betamethasone dipropionate/propylene glycol)
BETAMETHASONE DIPROPIONATE
CLOBETASOL EMOLLIENT (clobetasol propionate/emollient base)
CLOBETASOL PROPIONATE
DESONIDE
DESOXIMETASONE
FLUOCINOLONE ACETONIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAtopic dermatitis is a chronic, relapsing inflammatory disorder of the skin and the most common type of eczema.
While it predominantly presents during infancy and early childhood, it can affect individuals of any age and frequently co-occurs with other atopic manifestations such as asthma and allergic rhinitis.
Pathophysiologically, the condition arises from a complex interplay of epidermal barrier disruption, altered cutaneous immune activation primarily involving type 2 cytokine signaling, and microbial dysbiosis.
Clinically, it is characterized by intense pruritus, xerosis, and erythematous or scaly eczematous lesions that favor extensor surfaces in infants and flexural creases in older children and adults, often progressing to lichenification with chronic scratching.
- medlineplus.gov
Atopic dermatitis is a chronic, relapsing inflammatory disorder of the skin and the most common type of eczema
- aap.org
Atopic dermatitis is a chronic, relapsing inflammatory disorder of the skin and the most common type of eczema While it predominantly presents during infancy and early childhood, it can affect individuals of any age and frequently co-occurs with other atopic manifestations such as asthma and allergic rhinitis Pathophysiologically, the condition arises from a complex interplay of epidermal barrier disruption, altered cutaneous immune activation primarily involving type 2 cytokine signaling, and m...
- medlineplus.gov
While it predominantly presents during infancy and early childhood, it can affect individuals of any age and frequently co-occurs with other atopic manifestations such as asthma and allergic rhinitis
- nationaleczema.org
While it predominantly presents during infancy and early childhood, it can affect individuals of any age and frequently co-occurs with other atopic manifestations such as asthma and allergic rhinitis Clinically, it is characterized by intense pruritus, xerosis, and erythematous or scaly eczematous lesions that favor extensor surfaces in infants and flexural creases in older children and adults, often progressing to lichenification with chronic scratching
- nih.gov
Pathophysiologically, the condition arises from a complex interplay of epidermal barrier disruption, altered cutaneous immune activation primarily involving type 2 cytokine signaling, and microbial dysbiosis
- medlineplus.gov
Clinically, it is characterized by intense pruritus, xerosis, and erythematous or scaly eczematous lesions that favor extensor surfaces in infants and flexural creases in older children and adults, often progressing to lichenification with chronic scratching
Personalize your experience
Follow Atopic dermatitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.